Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization

AUTOR(ES)

Langenhan, Joseph M.

FONTE

National Academy of Sciences

RESUMO

Glycosylated natural products are reliable platforms for the development of many front-line drugs, yet our understanding of the relationship between attached sugars and biological activity is limited by the availability of convenient glycosylation methods. When a universal chemical glycosylation method that employs reducing sugars and requires no protection or activation is used, the glycorandomization of digitoxin leads to analogs that display significantly enhanced potency and tumor specificity and suggests a divergent mechanistic relationship between cardiac glycoside-induced cytotoxicity and Na+/K+-ATPase inhibition. This report highlights the remarkable advantages of glycorandomization as a powerful tool in glycobiology and drug discovery.

Documentos Relacionados

• Cardiac glycosides
• Plants and cardiac glycosides.
• Cardiac glycosides from Cascabela thevetioides by HPLC-MS analysis
• Structural insights into the binding of cardiac glycosides to the digitalis receptor revealed by solid-state NMR
• The electrogenic sodium pump in guinea-pig ventricular muscle: inhibition of pump current by cardiac glycosides